HiTIS - Life Science & Biotech Intelligence, A Global Life Sciences Industry Focused Competitive Intelligence Firm, Launched Skin Diseases Drug Development Weekly

Paris, France, February 12, 2007 --(PR.com)-- HiTIS – life science & biotech intelligence, a global life sciences industry focused competitive intelligence firm, added recently Skin Diseases Drug Development Weekly focused publication to its growing family of periodical competitive intelligence reports.

Skin Diseases Drug Development Weekly is a weekly publication reporting industry and academy news in a digital format. The reports cover the whole life cycle of drugs and diagnostics addressing those diseases, from lab-bench to patients, via regulatory process.

Diseases covered include acne, bacterial skin infections, benign tumors, bullous diseases, cancers of the skin (basal cell carcinoma, melanoma…), dermatitis, fungal and parasitic skin infections, hypersensitivity and inflammatory disorders, hair and nail disorders, pigmentation disorders, psoriasis and scaling diseases, reactions to sunlight, sweating disorders and viral skin diseases…

Collected news cover research, preclinical, clinical, regulatory, intellectual property, funding, collaborations, financial results (public companies) as well as M&A and legal issues.

A recent issue of this publication can be viewed at:

www.txpreview.com/SDDD%20Weekly%20-%20%20Y2007%20W02.htm

(copy/paste the link to your browser)

About The American Academy of Dermatology

The American Academy of Dermatology is the preeminent dermatologic association. With a membership of more than 15,000 physicians worldwide, the Academy is committed to:

- advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails
- advocating high standards in clinical practice, education, and research in dermatology; and
- supporting and enhancing patient care for a lifetime of healthier skin, hair and nails.

www.aad.org

About HiTIS Competitive Intelligence Publications

HiTIS Competitive Intelligence Publications family includes several focused electronic publications covering therapeutic fields or technologies, like:

Vaccines Competitive Intelligence Weekly, Neurodegenerative Diseases Tx/Dx Competitive Intelligence Weekly, Stents Competitive Intelligence Monthly, Eye Therapies Competitive Intelligence Weekly, Orphan Diseases Drug Development Weekly

Other similar publications will be announced in due time. Specific, customized publications may be developed upon request.

About HiTIS - life science & biotech intelligence (www.txpreview.com)

HiTIS - life science & biotech intelligence is a global competitive intelligence firm offering various intelligence resources and tools: a web-based competitive intelligence platform – www.biotech-intelligence.com - customized R&D Pipelines, and a series of periodical competitive intelligence publications. A free of charge 7-day news center trial and reports samples are available on request: see www.txpreview.com for more information

Contact

Christian Girard
Founding Partner & Editor
Mobile +33 (0)6 67 26 60 92
Office +33 (0)1 47 88 23 48
christian.girard@biotech-intelligence.com
www.biotech-intelligence.com and www.txpreview.com
HiTIS - life science & biotech intelligence
11, rue Madiraa - 92400 Courbevoie - France

###